DD289466A5 - Verwendung asymmetrischer membranen in freigabevorrichtungen - Google Patents

Verwendung asymmetrischer membranen in freigabevorrichtungen Download PDF

Info

Publication number
DD289466A5
DD289466A5 DD89332166A DD33216689A DD289466A5 DD 289466 A5 DD289466 A5 DD 289466A5 DD 89332166 A DD89332166 A DD 89332166A DD 33216689 A DD33216689 A DD 33216689A DD 289466 A5 DD289466 A5 DD 289466A5
Authority
DD
German Democratic Republic
Prior art keywords
weight
capsule
beads
membrane
release
Prior art date
Application number
DD89332166A
Other languages
German (de)
English (en)
Inventor
John R Cardinal
Scott M Herbig
Richard W Korsmeyer
Jeelin Lo
Kelly L Smith
Avinash G Thombre
Original Assignee
������@���Kk��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ������@���Kk�� filed Critical ������@���Kk��
Publication of DD289466A5 publication Critical patent/DD289466A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Executing Machine-Instructions (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Saccharide Compounds (AREA)
DD89332166A 1988-08-30 1989-08-29 Verwendung asymmetrischer membranen in freigabevorrichtungen DD289466A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23837188A 1988-08-30 1988-08-30

Publications (1)

Publication Number Publication Date
DD289466A5 true DD289466A5 (de) 1991-05-02

Family

ID=22897578

Family Applications (1)

Application Number Title Priority Date Filing Date
DD89332166A DD289466A5 (de) 1988-08-30 1989-08-29 Verwendung asymmetrischer membranen in freigabevorrichtungen

Country Status (26)

Country Link
EP (1) EP0357369B1 (es)
JP (1) JPH07112971B2 (es)
KR (1) KR920008701B1 (es)
CN (2) CN1058387C (es)
AT (1) ATE89162T1 (es)
AU (1) AU615104B2 (es)
CA (1) CA1338552C (es)
CZ (1) CZ277763B6 (es)
DD (1) DD289466A5 (es)
DE (1) DE68906488T2 (es)
DK (1) DK175178B1 (es)
EG (1) EG19189A (es)
ES (1) ES2041006T3 (es)
FI (1) FI102515B (es)
HU (1) HU222245B1 (es)
IE (1) IE62859B1 (es)
IL (1) IL91398A (es)
MX (1) MX173942B (es)
MY (1) MY104183A (es)
NO (1) NO179232C (es)
NZ (1) NZ230470A (es)
PL (1) PL163079B1 (es)
PT (1) PT91560B (es)
RU (2) RU1837873C (es)
YU (1) YU47422B (es)
ZA (1) ZA896586B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline
ES2067957T3 (es) * 1990-08-07 1995-04-01 Pfizer Uso de membranas polimerizadas interfacialmente en dispositivos de liberacion.
DK0550641T3 (da) * 1990-09-28 1994-08-22 Pfizer Dispenseringsanordning indeholdende et hydrofobt medium
JPH0733645A (ja) * 1992-05-28 1995-02-03 Elan Corp Plc 錠剤製剤
TW235239B (es) * 1992-11-20 1994-12-01 Pfizer
CA2150019C (en) * 1992-11-30 1999-01-05 Scott M. Herbig Supported liquid membrane delivery devices
US5358502A (en) * 1993-02-25 1994-10-25 Pfizer Inc PH-triggered osmotic bursting delivery devices
US5798119A (en) * 1995-06-13 1998-08-25 S. C. Johnson & Son, Inc. Osmotic-delivery devices having vapor-permeable coatings
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
CN1151783C (zh) * 1997-07-01 2004-06-02 辉瑞产品公司 舍曲林的缓释剂型
NZ501251A (en) * 1997-07-01 2001-09-28 Pfizer Sertraline salts and sustained-release dosage forms of sertraline
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
WO2000028989A1 (en) * 1998-11-12 2000-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
WO2000069418A1 (en) * 1999-05-17 2000-11-23 The Dow Chemical Company Process for making cellulose ether capsules with organic acids
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
JP2005526104A (ja) 2002-04-04 2005-09-02 ファイザー・プロダクツ・インク 味の良い咀嚼可能な錠剤
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
EP2417969A1 (en) 2004-10-21 2012-02-15 Aptalis Pharmatech, Inc. Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US20060105038A1 (en) * 2004-11-12 2006-05-18 Eurand Pharmaceuticals Limited Taste-masked pharmaceutical compositions prepared by coacervation
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
WO2007002872A2 (en) * 2005-06-29 2007-01-04 Alza Corporation Semi-permeable compositions providing reduced drying time for osmotic dosage forms
KR101405545B1 (ko) 2005-11-28 2014-07-03 마리누스 파마슈티컬스 ｇａｎａｘｏｌｏｎｅ 제형, 이의 제조방법 및 용도
EP2248541B1 (de) * 2009-05-07 2018-10-31 Biotronik Ag Medikamentenbeschichteter ballonkatheter und verfahren zur herstellung desselben
CN101773484B (zh) * 2009-05-12 2013-12-25 沈阳药科大学 胃漂浮渗透泵型非匀质膜胶囊缓控释系统及其制备方法
WO2011039686A1 (en) 2009-09-30 2011-04-07 Pfizer Inc. Latrepirdine oral sustained release dosage forms
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
US10898865B2 (en) * 2013-01-31 2021-01-26 American University In Cairo (AUC) Polymer-carbon nanotube nanocomposite porous membranes
JP6041823B2 (ja) 2013-03-16 2016-12-14 ファイザー・インク トファシチニブの経口持続放出剤形
WO2021014360A1 (en) 2019-07-23 2021-01-28 Pfizer Inc. Oral modified release dosage forms
US20220378707A1 (en) 2019-11-14 2022-12-01 Pfizer Inc. 1-(((2s,3s,4s)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide combinations and oral dosage forms
AU2021217209A1 (en) 2020-02-03 2022-09-29 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271831A (es) * 1960-11-29
ATE10582T1 (de) * 1981-01-22 1984-12-15 Capsugel A.G. Verfahren zur herstellung pharmazeutischer, darmloeslicher kapseln.
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
GB8322007D0 (en) * 1983-08-16 1983-09-21 Wellcome Found Pharmaceutical delivery system
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
DE10075031I2 (de) * 1984-08-17 2004-07-01 Wellcome Found Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy

Also Published As

Publication number Publication date
RU1837873C (ru) 1993-08-30
PT91560B (pt) 1995-05-04
IL91398A (en) 1994-05-30
JPH07112971B2 (ja) 1995-12-06
DK175178B1 (da) 2004-06-28
KR920008701B1 (ko) 1992-10-08
FI894046A0 (fi) 1989-08-29
AU4089189A (en) 1990-05-31
CZ277763B6 (en) 1993-04-14
CA1338552C (en) 1996-08-27
DE68906488T2 (de) 1993-09-09
IE62859B1 (en) 1995-03-08
IL91398A0 (en) 1990-04-29
NO179232B (no) 1996-05-28
EP0357369A2 (en) 1990-03-07
RU2093147C1 (ru) 1997-10-20
HU222245B1 (hu) 2003-05-28
NO893450D0 (no) 1989-08-29
MX173942B (es) 1994-04-11
KR900002821A (ko) 1990-03-23
CS501189A3 (en) 1992-12-16
DK424489D0 (da) 1989-08-29
NO179232C (no) 1996-09-04
ES2041006T3 (es) 1993-11-01
DK424489A (da) 1990-03-01
CN1125573A (zh) 1996-07-03
EP0357369A3 (en) 1991-10-02
FI102515B1 (fi) 1998-12-31
ZA896586B (en) 1991-04-24
PL163079B1 (pl) 1994-02-28
NO893450L (no) 1990-03-01
CN1042072A (zh) 1990-05-16
EP0357369B1 (en) 1993-05-12
ATE89162T1 (de) 1993-05-15
PT91560A (pt) 1990-03-30
HUT74086A (en) 1996-11-28
EG19189A (en) 1994-11-30
YU165789A (en) 1992-05-28
AU615104B2 (en) 1991-09-19
DE68906488D1 (de) 1993-06-17
CN1058387C (zh) 2000-11-15
FI102515B (fi) 1998-12-31
FI894046A (fi) 1990-03-01
IE892771L (en) 1990-02-28
JPH02174713A (ja) 1990-07-06
YU47422B (sh) 1995-03-27
MY104183A (en) 1994-02-28
NZ230470A (en) 1991-06-25

Similar Documents

Publication Publication Date Title
DE68906488T2 (de) Verwendung von asymmetrischen membranen in abgabevorrichtungen.
US5698220A (en) Asymmetric membranes in delivery devices
AT402689B (de) Dosierungsform für die behandlung kardiovaskulärererkrankungen
DE3310081C2 (de) Vorrichtung zur Abgabe von zwei unterschiedlichen Wirkstoffen durch Osmose
DE69107461T2 (de) Verwendung von interfacial polymerisierten membranen in abgabevorrichtungen.
DE60206078T2 (de) Pharmazeutische komposition für verlängerte/langanhaltende freisetzung eines therapeutisch aktiven wirkstoffes
DE3509410C2 (de) Abgabesystem zur Freisetzung einer Wirkstofformulierung
DE68907762T2 (de) Arzneizubereitung mit gesteuerter Wirkstofffreisetzung und Verfahren zu deren Herstellung.
DE3687799T2 (de) Osmotische pumpe fuer lipide.
AT397179B (de) Osmotische vorrichtung für die abgabe eines wirkstoffes
DE69524214T3 (de) Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
DE68904801T2 (de) Waesserige pharmazeutische ueberzuege fuer dosierformen.
EP0339506B1 (de) Orales osmotisches System mit verbesserter Haftwirkung der Membran am Kern
DE3613433A1 (de) Osmotische abgabevorrichtung
CN101518517B (zh) 药物剂量逐渐增加的剂型
DE3626362C2 (de) Abgabevorrichtung zur Freisetzung eines Wirkstoffes an Wiederkäuer
DE3613382A1 (de) Osmotische abgabevorrichtung
DE69320056T2 (de) Abgabevorrichtung mit eingekapselten hilfsmitteln
DE3542888A1 (de) Osmotische vorrichtung zur abgabe von wirkstoffen
CH636276A5 (de) Durch osmose betaetigbare abgabevorrichtung.
CH667589A5 (de) Abgabevorrichtung, ausgebildet fuer die programmierte abgabe von wirkstoffen an ein anwendungsmilieu, enthaltend eine arzneimittelformulierung.
DE2741755C2 (de) Überzugsmassen auf Polymerbasis für biologisch aktive Präparate, Verfahren zu ihrer Herstellung sowie mit diesen Überzugsmassen überzogene biologisch aktive Präparate und Verfahren zur Herstellung derselben
DE3626559C2 (de) Abgabevorrichtung zur Verabreichung eines Wirkstoffs an Wiederkäuer
EP0271438A2 (de) Orales osmotisches System für Metoprolol mit verbesserten Formulierungseigenschaften
DE68905343T2 (de) Dosisform zur verabreichung von calciumantagonisten.

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee